Tasquinimod for the Treatment of Relapsed or Refractory Myeloma
Summary
Third Opinion Trial Synopsis:
This is the first time doctors have tried using a drug called tasquinimod to treat people with a type of cancer called multiple myeloma. They want to see if the drug works.
This is the first time doctors have tried using a drug called tasquinimod to treat people with a type of cancer called multiple myeloma. They want to see if the drug works.
*Third Opinion AI Generated Synopsis
Trial Summary
This study is the first study of tasquinimod, an inhibitor of S100A9, in patients with multiple myeloma.
This study is the first study of tasquinimod, an inhibitor of S100A9, in patients with multiple myeloma.
Locations & Contact
Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.
Contacts: